Torben Plesner - Dissemin

Language
Login

All papers authored by Torben Plesner

This paper was not found in any repository, but could be made available legally by the author.

2021 Torben Plesner

ORCID

, Sung‐Soo Yoon, Meletios A. Dimopoulos

ORCID

, Dimopoulos Ma, Albert Oriol, Jesus San‐Miguel

ORCID

, Nizar J. Bahlis, Bahlis Nj, Neil Rabin, Kenshi Suzuki, Dina Ben‐Yehuda, Yoon Ss, Gordon Cook

ORCID

, Hartmut Goldschmidt, Sebastian Grosicki and 7 other authors

Health‐related quality of life in patients with relapsed or refractory multiple myeloma: treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial

Upload

This paper is made freely available by the publisher.

Torben Plesner

ORCID

Optimizing the Outcome of Anti-Myeloma Treatment with Daratumumab

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Sara Bringhen

ORCID

, Peter M. Voorhees

ORCID

, Torben Plesner

ORCID

, Ulf‐Henrik Mellqvist, Brandi Reeves, Pieter Sonneveld, Catriona Byrne, Eva Nordström, Johan Harmenberg, Jakob Obermüller, Paul G. Richardson

ORCID

Melflufen plus dexamethasone in relapsed/refractory multiple myeloma: long‐term survival follow‐up from the Phase II study O‐12‐M1

Upload

This paper is made freely available by the publisher.

2020 Torben Plesner

ORCID

, Niels W. C. J. van de Donk, Paul G. Richardson

Controversy in the Use of CD38 Antibody for Treatment of Myeloma: Is High CD38 Expression Good or Bad?

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2019 Torben Plesner

ORCID

“Fine‐tuning cytoreduction in resistant multiple myeloma ‐ progress here, too”?

Upload

This paper was not found in any repository, but could be made available legally by the author.

Torben Plesner

ORCID

, Hendrik‐Tobias Arkenau, Francesca Gay

ORCID

, Monique C. Minnema, Mario Boccadoro, Philippe Moreau

ORCID

, Jamie Cavenagh, Aurore Perrot, Jacob P. Laubach

ORCID

, Jakub Krejcik, Tahamtan Ahmadi, Carla de Boer, Diana Chen, Christopher Chiu, Jordan M. Schecter and 1 other authors

Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open‐label, phase 1/2 study

Upload

Missing publications? Search for publications with a matching author name.